Cancer risks in patients with chronic lymphocytic thyroiditis

Area of Science:

• Endocrinology
• Oncology
• Hematology

Background:

• Chronic lymphocytic thyroiditis (CLT) is an autoimmune condition.
• The association between CLT and secondary malignancies requires further investigation.
• Colloid goiter serves as a control condition for comparison.

Purpose of the Study:

• To analyze the incidence of malignant tumors and leukemia in patients with CLT compared to those with colloid goiter.
• To determine if CLT is associated with an increased risk of specific cancers, particularly hematologic malignancies.

Main Methods:

• A cohort study involving 829 patients with CLT and 829 matched controls with colloid goiter.
• Diagnoses confirmed via fine-needle aspiration biopsy cytology.
• Follow-up through the Swedish Cancer Register from 1959 to 1981.

Main Results:

• No increased risk for overall tumors or lung cancer in either group.
• Significantly elevated risk of myeloproliferative and lymphoproliferative neoplasms in the CLT group (12 observed vs. 3.0 expected; P < 0.001).
• A dramatically increased risk of malignant thyroid lymphoma in the CLT group (RR=67; 4 observed vs. 0.06 expected; P < 0.000001).

Conclusions:

• Chronic lymphocytic thyroiditis is associated with a substantially increased risk of developing myeloproliferative and lymphoproliferative neoplasms.
• Malignant lymphoma of the thyroid is a rare but significantly elevated risk in patients with CLT.
• Colloid goiter does not appear to confer an increased risk for any type of tumor.